Canaccord Genuity raises Beam Therapeutics' target price to $79 from $78
BEAM•Canaccord Genuity raised its target price for Beam Therapeutics to $79 from $78.
BEAM•BEAM•BEAM•Canaccord Genuity raised its target price for Beam Therapeutics to $79 from $78.
